Administration of Ifosfamide, Doxorubicin, and Mesna
Mesna must be administered concurrently with ifosfamide to prevent hemorrhagic cystitis, using either an all-intravenous regimen (60% total daily mesna dose) or a combined IV/oral regimen (100% total daily mesna dose), while doxorubicin is given as a separate infusion on day 1 of each cycle. 1
Mesna Administration Protocols
All-Intravenous Regimen (Standard-Dose Ifosfamide <2.5 g/m²/day)
For short infusion ifosfamide, administer mesna as three bolus IV injections totaling 60% of the ifosfamide dose: 2, 1
- 20% of ifosfamide dose given 15 minutes before ifosfamide administration
- 20% of ifosfamide dose given 4 hours after ifosfamide
- 20% of ifosfamide dose given 8 hours after ifosfamide
Example: For ifosfamide 1.2 g/m², give mesna 240 mg/m² at 0 hours, 240 mg/m² at 4 hours, and 240 mg/m² at 8 hours 1
Combined IV/Oral Regimen (For Ifosfamide ≤2.0 g/m²/day)
This FDA-approved alternative provides equivalent urothelial protection with improved convenience: 2, 1
- 20% of ifosfamide dose IV at time of ifosfamide administration
- 40% of ifosfamide dose orally at 2 hours after ifosfamide
- 40% of ifosfamide dose orally at 6 hours after ifosfamide
- Total daily mesna dose = 100% of ifosfamide dose
Critical caveat: If vomiting occurs within 2 hours of oral mesna, repeat the oral dose or switch to IV mesna 2, 1
Continuous Infusion Ifosfamide Protocol
For continuous-infusion ifosfamide, use this modified approach: 2
- 20% bolus of total ifosfamide dose before starting infusion
- 40% continuous infusion of ifosfamide dose, continuing for 12-24 hours after ifosfamide completion
Doxorubicin Administration
Standard Combination Regimens
In combination protocols with ifosfamide, doxorubicin dosing varies by regimen: 3, 4, 5, 6
- AIM regimen: Doxorubicin 60 mg/m² IV over 2 hours on day 1, with ifosfamide 2500 mg/m² on days 1-3 3
- Modified MAID: Doxorubicin 20 mg/m² over 0.5 hours on days 1-3, with ifosfamide 2500 mg/m² on days 1-3 4
- ECOG protocol: Doxorubicin 30 mg/m² on days 1-2, with ifosfamide 3750 mg/m² on days 1-2 5
Cycles are repeated every 21 days across all regimens 3, 4, 5
Practical Administration Details
Preparation and Compatibility
Mesna dilution: Dilute to final concentration of 20 mg/mL in 5% dextrose, normal saline, or lactated Ringer's solution 1
Critical incompatibility warning: Do not mix mesna with epirubicin, cyclophosphamide, cisplatin, carboplatin, or nitrogen mustard 1
Ifosfamide-mesna mixing: May be mixed in same bag only if final ifosfamide concentration does not exceed 50 mg/mL (benzyl alcohol in mesna vials reduces ifosfamide stability at higher concentrations) 1
Stability and Storage
- Diluted mesna solutions: Use within 24 hours when stored at 25°C (77°F) 1
- Multidose vials: May be used up to 8 days after initial puncture 1
Monitoring Requirements
Essential Surveillance
Maintain adequate hydration and monitor urine for hematuria throughout treatment 1
If severe hematuria develops despite appropriate mesna dosing, consider ifosfamide dose reduction or discontinuation 1
Hematologic monitoring is critical, as myelosuppression is the predominant toxicity with grade 3-4 neutropenia occurring in 47-88% of patients 3, 4, 5, 7
High-Dose Ifosfamide Considerations
For very high-dose ifosfamide (>2.5 g/m²/day), the optimal mesna dosing has not been established 2
Given the longer half-life at these doses, more frequent and prolonged mesna regimens may be necessary for maximum urotoxicity protection 2
The IV/oral regimen efficacy has not been established for daily ifosfamide doses higher than 2 g/m² 1